Familial Dysautonomia, Mutation Analysis, IVS20(+6T->C) and R696P
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Carrier screening for individuals of Ashkenazi Jewish ancestry
Prenatal diagnosis for at-risk pregnancies
Confirmation of a clinical diagnosis in individuals of Ashkenazi Jewish ancestry
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
|FBC||Fibroblast Culture for Genetic Test||Yes||No|
|AFC||Amniotic Fluid Culture/Genetic Test||Yes||No|
|MCC||Maternal Cell Contamination, B||Yes||No|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase chain reaction (PCR) analysis is used to test for the following mutations associated with familial dysautonomia: R696P and IVS20(+6)T->C.
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Familial Dysautonomia, Mutation
Hereditary Sensory and Autonomic Neuropathy, Type III